Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

World Hemoglobinopathies Market - Opportunities and Forecasts, 2014 - 2022 - Research and Markets

Research and Markets
Posted on: 31 Jul 17

The "World Hemoglobinopathies Market - Opportunities and Forecasts, 2014 - 2022" report has been added to Research and Markets' offering.

Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules, particularly defective globin chains. Hemoglobinopathies are inherited single-gene disorders of which sickle cell disease is the most common kind. There is a high prevalence of Hemoglobinopathies in Africa, Southeast Asia and the Mediterranean basin. If left untreated, critical cases of hemoglobinopathies lead to anemia, organ dysfunction or death.

Gel electrophoresis and complete blood count are used as diagnostic tests to determine the presence of hemoglobinopathies. The disease does not have a permanent cure; this has resulted in a growing demand for new product innovations in the pharmaceutical sector.

KEY BENEFITS

  • The report provides an overview of the global hemoglobinopathies market, which includes drivers, restraints and opportunities to help professionals better understand market behavior
  • Detailed information regarding R&D activities, pipeline research, partnerships, licensing and collaborations in the global hemoglobinopathies market would be informative for professionals in the corporate sector
  • Pin-point analysis of geographic segments would help stakeholders identify opportunities for growth within the global hemoglobinopathies market
  • Porter's Five Forces analysis examines the competitive structure of the global hemoglobinopathies market and would assist market strategists in their decision making process

KEY MARKET SEGMENTS

MARKET BY PIPELINE THERAPEUTICS

  • NiCord
  • ZFP Transcription Factors
  • ALN-TMP
  • Drug Targeting PRMT5
  • Drug Targeting Protein Arginine Methyltransferase 5

MARKET BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

For more information about this report visit https://www.researchandmarkets.com/research/vm8sq8/world

View source version on businesswire.com: http://www.businesswire.com/news/home/20170731005663/en/

Business Wire
www.businesswire.com

Last updated on: 31/07/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.